H
Humacyte, Inc. (HUMA)
NMS – Real vaqt narxi. Valyuta: USD
0.67
-0.04 (-6.34%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.66
-0.01 (-0.99%)
Bozordan keyin: Aug 12, 2026, 7:41 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
0.67
-0.04 (-6.34%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.66
-0.01 (-0.99%)
Bozordan keyin: Aug 12, 2026, 7:41 PM EDT
Humacyte, Inc. o'zining sho'ba korxonalari bilan birgalikda, bir nechta terapevtik sohalarda turli anatomik joylardagi kasalliklar va sharoitlarni davolash uchun tayyor, implantatsiya qilinadigan va bioinjenerlik qilingan inson to'qimalarini ishlab chiqish va ishlab chiqarish bilan shug'ullanadi. Kompaniya o'zining patentlangan ilmiy texnologik platformasidan foydalanib, inson akellular tomirlarini (HAVs) muhandislik va ishlab chiqaradi, ular bemorga begona jism reaktsiyasini qo'zg'atmasdan yoki immunitet rad etilishiga olib kelmasdan implantatsiya qilinadi. Kompaniya tomirlarni tiklash, rekonstruktsiya qilish va almashtirish bozoriga qaratilgan HAVs portfelini ishlab chiqmoqda, shu jumladan tomir shikastlanishlari; gemodializ uchun arteriyovenoz kirish; periferik arteriya kasalligi; bolalar yurak jarrohligi; va koroner arter bypass greftlash, shuningdek, hujayra terapiyasini etkazib berish uchun, shu jumladan 1-toifa diabetni davolash uchun oshqozon osti bezi orolcha hujayralarini ko'chirib o'tkazish. Humacyte, Inc. 2004 yilda tashkil etilgan bo'lib, shtab-kvartirasi Shimoliy Karolina shtatining Dyurhem shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Heather Connelly Ph.D. | Chief Quality & Regulatory Officer |
| Dr. Laura E. Niklason M.D., Ph.D. | Founder, President, CEO & Director |
| Dr. Shamik J. Parikh M.D. | Chief Medical Officer |
| Dr. Todd E. Rasmussen M.D. | Chief Surgical Officer |
| Mr. Dale A. Sander | CFO, Chief Corporate Development Officer & Treasurer |
| Mr. Jim Mercadante | Chief Commercial Officer |
| Mr. Rick McElheny | Senior Vice President of Business Development |
| Ms. Lisa Molyneux | Chief Strategy Officer |
| Ms. Sabrina Osborne GPHR, SPHR | Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-31 | 8-K | tm2621850d1_8k.htm |
| 2026-06-11 | 8-K | tm2617224d2_8k.htm |
| 2026-06-10 | 8-K | tm2617224d1_8k.htm |
| 2026-06-09 | 8-K | tm2617355d1_8k.htm |
| 2026-06-05 | 8-K | tm2616944d2_8k.htm |
| 2026-05-14 | S-8 | tm2614662d1_s8.htm |
| 2026-05-13 | 10-Q | huma-20260331.htm |
| 2026-05-08 | 8-K | tm2614071d1_8k.htm |
| 2026-04-28 | DEF 14A | huma-20260428.htm |
| 2026-04-24 | 8-K | tm2612631d1_8k.htm |